Regenxbio Inc (RGNX) showcases robust financial positioning and strategic progress in gene therapy, despite challenges in ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...

Pakistan’s military accused neighboring India on Friday of sponsoring insurgents in a restive southwestern province, where an ...

Topline data from Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT study reinforces ...

The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the ...

After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the ...

In Thursday's meeting, the director of the FDA's Center for Drug Evaluation and Research said plans for coming layoffs were ...

The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.

But beware. Health and Human Services Secretary Robert F. Kennedy, Jr. has called for “conflict-free” advisory committee ...

At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

The suspect in the train arson case in Yogyakarta revealed to the police that his motive stemmed from resentment towards ...